Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833235 · ClinicalTrials.gov registry record
A Natural History Study of Patients With Dry Eye
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 284
- Enrollment target
NCT00833235: Completed study, sponsored by Allergan.
NCT00833235 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 284 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00833235 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 284 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.
Interventions
- OTHER Artificial Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2009-02-01 |
| Est. Completion | 2017-03-06 |
What the finished NCT00833235 record still lists
NCT00833235 is an observational study that tracks outcomes without assigning an intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Artificial Tears is the first listed.
NCT00833235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00833235 about?
NCT00833235 is a clinical study titled "A Natural History Study of Patients With Dry Eye". This is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.
What is the current status of trial NCT00833235?
This trial is currently completed. The enrollment target is 284 participants. The study started on 2009-02-01. Estimated completion is 2017-03-06.
What interventions are being tested in trial NCT00833235?
The interventions under investigation include: Artificial Tears (OTHER).
Who is sponsoring clinical trial NCT00833235?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI